Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
A Study Protocol for a Comprehensive Evaluation of Two Artificial Intelligence‐Based Tools in Title and Abstract Screening for the Development of Evidence‐Based Cancer Guidelines
6
Zitationen
5
Autoren
2025
Jahr
Abstract
This will be the first study to investigate and compare the performance of DistillerSR and EPPI-Reviewer in Stage I screening of SRs in CPGs across different cancer types. These findings will inform the reliable use of AI tools in future cancer-related CPGs. The results from this retrospective study will need to be confirmed by prospective studies.
Ähnliche Arbeiten
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 62.834 Zit.
Cochrane Handbook for Systematic Reviews of Interventions
2008 · 25.008 Zit.
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
2008 · 21.046 Zit.
The National Comprehensive Cancer Network
1998 · 16.869 Zit.
Evidence based medicine: what it is and what it isn't
1996 · 15.514 Zit.